Literature DB >> 17123757

Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.

A M A Elhissi1, M Faizi, W F Naji, H S Gill, K M G Taylor.   

Abstract

The aerosol properties of liposomes and their physical stability to aerosolization were evaluated using an air-jet nebulizer (Pari LC Plus) and a customized large aperture vibrating-mesh nebulizer (Aeroneb Pro-8microm). Soya phosphatidylcholine: cholesterol (1:1 mole ratio) multilamellar liposomes (MLVs) entrapping salbutamol sulfate were nebulized directly, or after being reduced in size by extrusion through 1 or 0.4microm polycarbonate membrane filters. MLVs were very unstable to jet nebulization and stability was not markedly enhanced when vesicles were extruded before nebulization, such that drug losses from delivered liposomes using the Pari nebulizer were up to 88% (i.e. only 12% retained in liposomes). The Aeroneb Pro-8microm nebulizer was less disruptive to liposomes, completed nebulization in a much shorter time, and produced greater mass output rate than the Pari nebulizer. However, aerosol droplets were larger, total drug and mass outputs were lower and aerosolization performance was dependent on formulation. Vibrating-mesh nebulization was less disruptive to liposomes extruded through the 1microm membranes compared with the non-extruded MLVs, so that the retained entrapment of the drug in the nebulized vesicles was 56% and 37%, respectively. However, extrusion of liposomes to 0.4microm resulted in reduced stability of liposomes to vibrating-mesh nebulization (retained entrapment=41%) which was attributed to the reduced liposome lamellarity and subsequent reduced resistance to nebulization-induced shearing. This study has shown that vibrating-mesh nebulization using the customized large aperture mesh nebulizer (Aeroneb Pro-8microm) had a less disruptive effect on liposomes and produced a higher output rate compared with the Pari LC Plus air-jet nebulizer. On the other hand, the air-jet nebulizer produced higher total mass and drug outputs and smaller aerosol droplets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17123757     DOI: 10.1016/j.ijpharm.2006.10.022

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

Review 1.  Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations.

Authors:  Cheng Loong Ngan; Azren Aida Asmawi
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Severe intraoperative bronchospasm treated with a vibrating-mesh nebulizer.

Authors:  Leonard R Golden; Helen Ann DeSimone; Farhad Yeroshalmi; Mindaugas Pranevicius; Mana Saraghi
Journal:  Anesth Prog       Date:  2012

3.  Nebulised Gadolinium-Based Nanoparticles for a Multimodal Approach: Quantitative and Qualitative Lung Distribution Using Magnetic Resonance and Scintigraphy Imaging in Isolated Ventilated Porcine Lungs.

Authors:  Yoann Montigaud; Jérémie Pourchez; Lara Leclerc; Olivier Tillement; Anthony Clotagatide; Clémence Bal; Noël Pinaud; Nobuyasu Ichinose; Bei Zhang; Sophie Perinel; François Lux; Yannick Crémillieux; Nathalie Prevot
Journal:  Int J Nanomedicine       Date:  2020-09-30

4.  Nebulisation of receptor-targeted nanocomplexes for gene delivery to the airway epithelium.

Authors:  Maria D I Manunta; Robin J McAnulty; Aristides D Tagalakis; Stephen E Bottoms; Frederick Campbell; Helen C Hailes; Alethea B Tabor; Geoffrey J Laurent; Christopher O'Callaghan; Stephen L Hart
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

Review 5.  Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis.

Authors:  Melissa Skibba; Adam Drelich; Michael Poellmann; Seungpyo Hong; Allan R Brasier
Journal:  Front Pharmacol       Date:  2020-12-11       Impact factor: 5.810

Review 6.  Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections.

Authors:  Xiang Wang; Zuozhou Xie; Jinhong Zhao; Zhenghua Zhu; Chen Yang; Yi Liu
Journal:  Front Cell Infect Microbiol       Date:  2021-12-06       Impact factor: 5.293

7.  Aerosol performance and long-term stability of surfactant-associated liposomal ciprofloxacin formulations with modified encapsulation and release properties.

Authors:  David Cipolla; Huiying Wu; Igor Gonda; Hak-Kim Chan
Journal:  AAPS PharmSciTech       Date:  2014-06-03       Impact factor: 3.246

Review 8.  Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery.

Authors:  Ji Young Yhee; Jintaek Im; Richard Seonghun Nho
Journal:  J Clin Med       Date:  2016-09-20       Impact factor: 4.241

Review 9.  Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.

Authors:  Mindaugas Rudokas; Mohammad Najlah; Mohamed Albed Alhnan; Abdelbary Elhissi
Journal:  Med Princ Pract       Date:  2016-03-02       Impact factor: 1.927

10.  A Facile and Novel Approach to Manufacture Paclitaxel-Loaded Proliposome Tablet Formulations of Micro or Nano Vesicles for Nebulization.

Authors:  Iftikhar Khan; Katie Lau; Ruba Bnyan; Chahinez Houacine; Matthew Roberts; Abdullah Isreb; Abdelbary Elhissi; Sakib Yousaf
Journal:  Pharm Res       Date:  2020-06-02       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.